NMPA Approval

Emtricitabine and Tenofovir Alafenamide Fumarate Tablets(Ⅱ)

Approval Number

H20180067

Registration Date

November 21, 2018

Drug Information

Generic Name

恩曲他滨丙酚替诺福韦片(Ⅱ)

Dosage Form

片剂

Strength

每片含200mg恩曲他滨,25mg丙酚替诺福韦

Drug Type

化学药品

Registration Date

November 21, 2018

Expiry Date

November 20, 2023

Company Address

333 Lakeside Drive, Foster City, CA 94404 United States of America

Company NamePatheon Inc

Company Address

2100 Syntex Court, Mississauga, Ontario L5N 7K9, Canada

Empowering clinical research with data-driven insights and AI-powered tools.

恩曲他滨丙酚替诺福韦片(Ⅱ) - NMPA 批准文号 | MedPath